---
document_datetime: 2025-11-05 15:39:38
document_pages: 15
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/pylclari-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: pylclari-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 7.9032578
conversion_datetime: 2025-12-23 08:20:17.557404
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Pylclari

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | This was an application for a group of | 05/11/2025                          |                                             | Annex II and                     |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000304179   | variations.   | PL   |
|---------------------|---------------|------|

<div style=\"page-break-after: always\"></div>

| manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.f Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted B.II.b.2.c Replacement or addition of a   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| and/or batch release - B.II.b.2.c.2 Including     |
|---------------------------------------------------|
| batch control/testing - Accepted                  |
| B.II.b.2.c Replacement or addition of a           |
| manufacturer responsible for importation          |
| and/or batch release - B.II.b.2.c.2 Including     |
| batch control/testing - Accepted                  |
| B.I.a.1 Change in the manufacturer of a           |
| starting material/reagent/intermediate used       |
| in the manufacturing process of the active        |
| substance or change in the manufacturer           |
| (including where relevant quality control         |
| testing sites) of the active substance, where     |
| no Ph. Eur. Certificate of Suitability is part of |
| the approved dossier - B.I.a.1.a The              |
| proposed manufacturer is part of the same         |
| pharmaceutical group as the currently             |
| approved manufacturer - Accepted                  |
| B.I.a.1 Change in the manufacturer of a           |
| starting material/reagent/intermediate used       |
| in the manufacturing process of the active        |
| substance or change in the manufacturer           |
| (including where relevant quality control         |
| testing sites) of the active substance, where     |
| no Ph. Eur. Certificate of Suitability is part of |
| the approved dossier - B.I.a.1.a The              |
| proposed manufacturer is part of the same         |
| pharmaceutical group as the currently             |
| approved manufacturer - Accepted                  |

<div style=\"page-break-after: always\"></div>

|                                       | B.II.b.2 Change to importer, batch release arrangements and quality control testing of the finished product - B.II.b.2.a Replacement or addition of a site where batch control/testing takes place - Accepted B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.a Minor change in the manufacturing process - Accepted B.II.c.3 Change in source of an excipient or reagent with TSE risk - B.II.c.3.z Change in source of excipient unlikely to present any risk of TSE contamination - Accepted B.II.c.3 Change in source of an excipient or reagent with TSE risk - B.II.c.3.z Change in source of excipient unlikely to present any risk of TSE contamination - Accepted B.II.c.3 Change in source of an excipient or reagent with TSE risk - B.II.c.3.z Change in source of excipient unlikely to present any risk of TSE contamination - Accepted   |            |                        |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------------------|
| Variation type IB / EMA/VR/0000279041 | This was an application for a group of variations. B.II.b.1 Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 21/07/2025 | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

| manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.f Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.f Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.f Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products - Accepted   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.f Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.f Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| site - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary site - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary site - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| packaging                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| packaging                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| packaging                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| site - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| B.II.b.2.c Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| manufacturer responsible for importation                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| and/or batch release - B.II.b.2.c.2 Including                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| batch control/testing - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| B.II.b.2.c Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| manufacturer responsible for importation                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| and/or batch release - B.II.b.2.c.2 Including                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| batch control/testing - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| B.II.b.2.c Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| manufacturer responsible for importation                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

<div style=\"page-break-after: always\"></div>

| and/or batch release - B.II.b.2.c.2 Including batch control/testing - Accepted B.II.b.2.c Replacement or addition of a manufacturer responsible for importation and/or batch release - B.II.b.2.c.2 Including batch control/testing - Accepted B.II.b.2.c Replacement or addition of a manufacturer responsible for importation and/or batch release - B.II.b.2.c.2 Including batch control/testing - Accepted B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in the manufacturing process of the active substance or change in the manufacturer   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (including where relevant quality control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| testing sites) of the active substance, where                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| no Ph. Eur. Certificate of Suitability is part of                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| the approved dossier - B.I.a.1.a The                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| proposed manufacturer is part of the same                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| pharmaceutical group as the currently                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| approved manufacturer - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| B.I.a.1 Change in the manufacturer of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| starting material/reagent/intermediate used                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| in the manufacturing process of the active                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| substance or change in the manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| (including where relevant quality control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| testing sites) of the active substance, where                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| no Ph. Eur. Certificate of Suitability is part of                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

| the approved dossier - B.I.a.1.z Other            |
|---------------------------------------------------|
| variation - Accepted                              |
| B.I.a.1 Change in the manufacturer of a           |
| starting material/reagent/intermediate used       |
| in the manufacturing process of the active        |
| substance or change in the manufacturer           |
| (including where relevant quality control         |
| testing sites) of the active substance, where     |
| no Ph. Eur. Certificate of Suitability is part of |
| the approved dossier - B.I.a.1.z Other            |
| variation - Accepted                              |
| B.I.a.1 Change in the manufacturer of a           |
| starting material/reagent/intermediate used       |
| in the manufacturing process of the active        |
| substance or change in the manufacturer           |
| (including where relevant quality control         |
| testing sites) of the active substance, where     |
| no Ph. Eur. Certificate of Suitability is part of |
| the approved dossier - B.I.a.1.z Other            |
| variation - Accepted                              |
| B.II.b.2 Change to importer, batch release        |
| arrangements and quality control testing of       |
| the finished product - B.II.b.2.a                 |
| batch control/testing takes place -               |
| Accepted                                          |
| in the manufacturing process of the active        |
| starting material/reagent/intermediate used       |

<div style=\"page-break-after: always\"></div>

|                                       | substance or change in the manufacturer (including where relevant quality control testing sites) of the active substance, where no Ph. Eur. Certificate of Suitability is part of the approved dossier - B.I.a.1.a The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer - Accepted B.II.d.2 Change in test procedure for the finished product - B.II.d.2.d Other changes to a test procedure (including replacement or addition) - Accepted B.II.d.2 Change in test procedure for the finished product - B.II.d.2.d Other changes to a test procedure (including replacement or addition) - Accepted B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.a Minor change in the manufacturing process - Accepted B.II.c.3 Change in source of an excipient or reagent with TSE risk - B.II.c.3.z Other   |            |                         |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-------------------------|
| Variation type IB / EMA/VR/0000262275 | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 26/05/2025 | Annex II, Labelling and |

<div style=\"page-break-after: always\"></div>

| B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.f Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.f Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.f Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically   | PL   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------|

<div style=\"page-break-after: always\"></div>

| immunological medicinal products - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted B.II.b.2.c Replacement or addition of a manufacturer responsible for importation and/or batch release - B.II.b.2.c.2 Including batch control/testing - Accepted B.II.b.2.c Replacement or addition of a manufacturer responsible for importation and/or batch release - B.II.b.2.c.2 Including batch control/testing - Accepted B.II.b.2.c Replacement or addition of a manufacturer responsible for importation   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| and/or batch release - B.II.b.2.c.2 Including     |
|---------------------------------------------------|
| batch control/testing - Accepted                  |
| B.I.a.1 Change in the manufacturer of a           |
| starting material/reagent/intermediate used       |
| in the manufacturing process of the active        |
| substance or change in the manufacturer           |
| (including where relevant quality control         |
| testing sites) of the active substance, where     |
| no Ph. Eur. Certificate of Suitability is part of |
| the approved dossier - B.I.a.1.a The              |
| proposed manufacturer is part of the same         |
| pharmaceutical group as the currently             |
| approved manufacturer - Accepted                  |
| B.I.a.1 Change in the manufacturer of a           |
| starting material/reagent/intermediate used       |
| in the manufacturing process of the active        |
| substance or change in the manufacturer           |
| (including where relevant quality control         |
| testing sites) of the active substance, where     |
| no Ph. Eur. Certificate of Suitability is part of |
| the approved dossier - B.I.a.1.a The              |
| proposed manufacturer is part of the same         |
| pharmaceutical group as the currently             |
| approved manufacturer - Accepted                  |
| B.I.a.1 Change in the manufacturer of a           |
| starting material/reagent/intermediate used       |
| in the manufacturing process of the active        |
| substance or change in the manufacturer           |

<div style=\"page-break-after: always\"></div>

|                            | testing sites) of the active substance, where no Ph. Eur. Certificate of Suitability is part of the approved dossier - B.I.a.1.a The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer - Accepted   |             |
|----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|
| PSUR / EMA/PSUR/0000257788 | - -                                                                                                                                                                                                                                                     | Maintenance |